Journal of Clinical Oncology
Articles in this Issue
Optimal prostate-specific antigen cutoff for prostate cancer detection: A prospective cohort study.
5109 Background: Serum prostate-specific antigen (PSA) testing is crucial for detecting early stage and low-risk prostate...
Oncology clinicians’ empathy association with mean number of visits and referrals to psychosocial oncology services.
e24125 Background: Referrals to psychosocial services is not standardized despite national mandates for distress screening...
Real-world feasibility and efficacy of a tailored exercise program in patients with cancer.
12040 Background: Exercise (EX) is associated with improved survival, symptom control, and management of treatment-related...
Divergence between progression-free and overall survival treatment effect sizes in antibody-drug conjugate trials: A meta-epidemiologic study.
e13076 Background: Progression-free survival (PFS) is frequently used as a primary endpoint in contemporary oncology trial...
Identifying exposome-driven cancer incidence patterns using multi-cancer principal components analysis.
e22606 Background: Populations are exposed to complex mixtures of environmental, behavioral, and social factors that influ...
Patient-reported global health to predict negative health outcomes in patients with advanced sarcoma.
11554 Background: Many patients with sarcoma deal with adverse impacts on their (QoL) related to their underlying disease...
Differential effects of Acuity Circles policy on waitlist outcomes in hepatocellular carcinoma transplantation by region, insurance status, and ethnicity.
e23251 Background: The Acuity Circles (AC) policy replaced Donation Service Areas with distance-based sharing to mitigate...
Impact of aryl hydrocarbon receptor (AHR) modulation on survival in pre-clinical head and neck models via microbial tryptophan pathway.
e14594 Background: Metastatic head and neck squamous cell carcinoma (HNSCC) remains associated with poor outcomes. We have...
Outcomes of surgical resection combined with intraoperative cesium-131 brachytherapy in brain metastases: A systematic review and meta-analysis.
e14014 Background: Local control after surgical resection of brain metastases remains difficult to achieve. Although posto...
Weekend admission and early in-hospital mortality among patients with hematologic malignancies admitted for febrile neutropenia.
11087 Background: Weekend admissions have been associated with worse health outcomes compared with weekday admissions, a p...
Influence of neoadjuvant spatially fractionated stereotactic body radiotherapy on antitumor immunity and pathological response to toripalimab-based immunochemotherapy in resectable stage IIA-IIIB non-small cell lung cancer.
8046 Background: Neoadjuvant immunochemotherapy has improved outcomes in resectable non–small cell lung cancer (NSCLC); ho...
A quality improvement initiative to improve genomic testing rates in patients with prostate cancer.
e23316 Background: The therapeutic landscape of metastatic prostate cancer has rapidly evolved with the integration of pre...
WINSHIP 4468-18: Phase II evaluation of the effect of 2- versus 6-hour oxaliplatin infusions on neuropathy and pharmacokinetics in patients with gastrointestinal cancers.
TPS12174 Background: Oxaliplatin, a third-generation platinum agent, improves outcomes in gastrointestinal (GI) cancers wh...
Perceptions of supportive care among patients with stage IV or recurrent cancer in a community oncology setting.
e24078 Background: Early integration of supportive and palliative care (SC/PC) improves outcomes for patients with advance...
Is adjuvant chemotherapy associated with improved survival for patients with a complete pathological response to neoadjuvant chemotherapy for pancreatic adenocarcinoma?: A population-based analysis.
e16453 Background: The treatment for localized pancreatic adenocarcinoma often involves neoadjuvant chemotherapy and surgi...
Definitive non-surgical management of locally advanced esophageal adenocarcinoma: A systematic review and meta-analysis.
e16143 Background: For patients with Locally Advanced Esophageal Adenocarcinoma (LAEA), esophagectomy with perioperative c...
NICE-TIL (NKG2D-CAR/mbIL15/tEGFR-transduced TILs) and antitumor activity via dual TCR-HLA and NKG2D-NKG2DL killing pathways.
e21506 Background: CAR-T therapy’s efficacy in solid tumors is limited by T-cell dysfunction, heterogeneous antigen expres...
Prospective prediction of alisertib-induced Aurora-A kinase resistance mutations in patients with metastatic ER+ breast cancer using an innovative artificial intelligence approach.
3022 Background: Pharmacological blockade of Aurora-A mitotic kinase (AURKA) oncogenic pathway represents a promising ther...
Impact of engineered probiotic expressing FomA-targeted antimicrobial peptides on intestinal tumorigenesis in a mouse model of <i>Fusobacterium nucleatum</i> –associated colorectal cancer.
e15157 Background: Fusobacterium nucleatum ( Fn ) is one of th...
Minimal residual disease ctDNA testing in metastatic breast cancer patients with no radiological evidence of disease: Potentialclinical utility from real-worlddata.
e13075 Background: Liquid biopsy is increasingly recognized as a valuable tool for disease monitoring in metastatic breast...
Beyond cellular locality: Vision transformer–based modeling for diagnosis and classification of blood cancers from peripheral blood smears.
e18562 Background: Accurate morphologic assessment of peripheral blood smears remains central to hematologic malignancy di...
Real-world outcomes of nasopharyngeal carcinoma in a 20-year retrospective cohort from a lower-middle income country.
e18093 Background: Nasopharyngeal carcinoma (NPC) is frequently diagnosed at advanced stages in low- and middle-income cou...
A multicenter phase II trial of encorafenib, binimetinib, and cetuximab for early relapsed stage II/III <i>BRAF</i> <sup>V600E</sup> -mutated colorectal cancer: TRESBIEN trial (OGSG 2101).
3567 Background: Patients with BRAF V600E...
Cetuximab in combination with immunotherapy and chemotherapy as preoperative induction therapy for locally advanced HNSCC: A retrospective study.
e18027 Background: The survival of head and neck squamous cell carcinoma (HNSCC) patients has improved with the use of ant...
Outcomes after unrelated donor allogeneic hematopoietic cell transplantation in age ≥65 using post-transplant cyclophosphamide.
6560 Background: The use of allogeneic hematopoietic cell transplantation (allo-HCT) in older adults has increased with re...